Seelos Therapeutics, Inc. (SEEL)
NASDAQ: SEEL · IEX Real-Time Price · USD
0.546
+0.022 (4.28%)
At close: Jul 19, 2024, 4:00 PM
0.540
-0.006 (-1.08%)
Pre-market: Jul 22, 2024, 7:21 AM EDT

Seelos Therapeutics Statistics

Total Valuation

SEEL has a market cap or net worth of $1.56 million. The enterprise value is $14.17 million.

Market Cap 1.56M
Enterprise Value 14.17M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, before market open.

Earnings Date Aug 12, 2024
Ex-Dividend Date n/a

Share Statistics

SEEL has 2.86 million shares outstanding. The number of shares has increased by 246.73% in one year.

Shares Outstanding 2.86M
Shares Change (YoY) +246.73%
Shares Change (QoQ) +165.45%
Owned by Insiders (%) 1.20%
Owned by Institutions (%) 17.88%
Float 2.15M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.79
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 7.18
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.10

Current Ratio 0.10
Quick Ratio 0.04
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -296.97

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -399.70%
Return on Capital (ROIC) n/a
Revenue Per Employee $123,375
Profits Per Employee -$1.69M
Employee Count 16
Asset Turnover 0.29
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -99.86% in the last 52 weeks. The beta is 1.89, so SEEL's price volatility has been higher than the market average.

Beta (5Y) 1.89
52-Week Price Change -99.86%
50-Day Moving Average 1.10
200-Day Moving Average 12.67
Relative Strength Index (RSI) 33.44
Average Volume (20 Days) 1,314,178

Short Selling Information

The latest short interest is 136,114, so 4.76% of the outstanding shares have been sold short.

Short Interest 136,114
Short Previous Month 215,571
Short % of Shares Out 4.76%
Short % of Float 6.34%
Short Ratio (days to cover) 0.98

Income Statement

In the last 12 months, SEEL had revenue of $1.97 million and -$27.12 million in losses. Loss per share was -$82.64.

Revenue 1.97M
Gross Profit 1.97M
Operating Income -37.62M
Pretax Income -27.12M
Net Income -27.12M
EBITDA -26.97M
EBIT -27.02M
Loss Per Share -$82.64
Full Income Statement

Balance Sheet

The company has $524,000 in cash and $13.14 million in debt, giving a net cash position of -$12.61 million or -$4.41 per share.

Cash & Cash Equivalents 524,000
Total Debt 13.14M
Net Cash -12.61M
Net Cash Per Share -$4.41
Equity (Book Value) -33.10M
Book Value Per Share -11.58
Working Capital -33.17M
Full Balance Sheet

Cash Flow

Operating Cash Flow -18.21M
Capital Expenditures n/a
Free Cash Flow -18.21M
FCF Per Share -$11.20
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -1,905.88% and -1,373.61%.

Gross Margin 100.00%
Operating Margin -1,905.88%
Pretax Margin -1,373.61%
Profit Margin -1,373.61%
EBITDA Margin -1,366.06%
EBIT Margin -1,369.00%
FCF Margin -922.29%

Dividends & Yields

SEEL does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -246.73%
Shareholder Yield -246.73%
Earnings Yield -1,736.86%
FCF Yield -1,166.19%

Analyst Forecast

The average price target for SEEL is $240.00, which is 43,864.10% higher than the current price. The consensus rating is "Hold".

Price Target $240.00
Price Target Difference 43,864.10%
Analyst Consensus Hold
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on May 16, 2024. It was a reverse split with a ratio of 1:8.

Last Split Date May 16, 2024
Split Type Reverse
Split Ratio 1:8

Scores

SEEL has an Altman Z-Score of -134.09 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -134.09
Piotroski F-Score 2